메뉴 건너뛰기




Volumn 14, Issue 3, 2012, Pages 554-558

Physiochemical and biochemical factors influencing the pharmacokinetics of antibody therapeutics

Author keywords

antibody; FcRn; glycosylation; isoelectric point; pharmacokinetics

Indexed keywords

ALEFACEPT; ANTIBODY; FC RECEPTOR; GOLIMUMAB; IMMUNOGLOBULIN G; INDIUM 111; MANNOSE; MONOCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

EID: 84862772871     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-012-9369-y     Document Type: Review
Times cited : (99)

References (40)
  • 1
    • 33947304452 scopus 로고    scopus 로고
    • The pharmacokinetics and pharmacodynamics of monoclonal antibodies-mechanistic modeling applied to drug development
    • 1:CAS:528:DC%2BD2sXpsVGksw%3D%3D
    • DR Mould KR Sweeney 2007 The pharmacokinetics and pharmacodynamics of monoclonal antibodies-mechanistic modeling applied to drug development Curr Opin Drug Discov Dev 10 1 84 96 1:CAS:528:DC%2BD2sXpsVGksw%3D%3D
    • (2007) Curr Opin Drug Discov Dev , vol.10 , Issue.1 , pp. 84-96
    • Mould, D.R.1    Sweeney, K.R.2
  • 2
    • 0026507779 scopus 로고
    • Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc gamma receptor
    • 1533898 10.1016/0161-5890(92)90200-H 1:CAS:528:DyaK38XktVGkt7w%3D
    • G Sarmay J Lund Z Rozsnyay J Gergely R Jefferis 1992 Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc gamma receptor Mol Immunol 29 5 633 9 1533898 10.1016/0161-5890(92)90200-H 1:CAS:528:DyaK38XktVGkt7w%3D
    • (1992) Mol Immunol , vol.29 , Issue.5 , pp. 633-639
    • Sarmay, G.1    Lund, J.2    Rozsnyay, Z.3    Gergely, J.4    Jefferis, R.5
  • 3
    • 77953681422 scopus 로고    scopus 로고
    • Stability of IgG isotypes in serum
    • 20404539 10.4161/mabs.2.3.11788
    • IR Correia 2010 Stability of IgG isotypes in serum mAbs 2 3 221 32 20404539 10.4161/mabs.2.3.11788
    • (2010) MAbs , vol.2 , Issue.3 , pp. 221-232
    • Correia, I.R.1
  • 4
    • 78751499845 scopus 로고    scopus 로고
    • Quantitative prediction of human pharmacokinetics for monoclonal antibodies: Retrospective analysis of monkey as a single species for first-in-human prediction
    • 21241072 10.2165/11537430-000000000-00000 1:CAS:528:DC%2BC3MXjtFCntLo%3D
    • JQ Dong DH Salinger CJ Endres JP Gibbs CP Hsu BJ Stouch, et al. 2011 Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction Clin Pharmacokinet 50 2 131 42 21241072 10.2165/11537430-000000000- 00000 1:CAS:528:DC%2BC3MXjtFCntLo%3D
    • (2011) Clin Pharmacokinet , vol.50 , Issue.2 , pp. 131-142
    • Dong, J.Q.1    Salinger, D.H.2    Endres, C.J.3    Gibbs, J.P.4    Hsu, C.P.5    Stouch, B.J.6
  • 5
    • 54249138516 scopus 로고    scopus 로고
    • Monoclonal antibody pharmacokinetics and pharmacodynamics
    • 18784655 10.1038/clpt.2008.170 1:CAS:528:DC%2BD1cXht1OisLvM
    • W Wang EQ Wang JP Balthasar 2008 Monoclonal antibody pharmacokinetics and pharmacodynamics Clin Pharmacol Ther 84 5 548 58 18784655 10.1038/clpt.2008.170 1:CAS:528:DC%2BD1cXht1OisLvM
    • (2008) Clin Pharmacol Ther , vol.84 , Issue.5 , pp. 548-558
    • Wang, W.1    Wang, E.Q.2    Balthasar, J.P.3
  • 6
    • 32444438731 scopus 로고    scopus 로고
    • Elimination mechanisms of therapeutic monoclonal antibodies
    • 16478695 10.1016/S1359-6446(05)03638-X 1:CAS:528:DC%2BD28XhsFygt70%3D
    • MA Tabrizi CM Tseng LK Roskos 2006 Elimination mechanisms of therapeutic monoclonal antibodies Drug Discov Today 11 1-2 81 8 16478695 10.1016/S1359-6446(05)03638-X 1:CAS:528:DC%2BD28XhsFygt70%3D
    • (2006) Drug Discov Today , vol.11 , Issue.12 , pp. 81-88
    • Tabrizi, M.A.1    Tseng, C.M.2    Roskos, L.K.3
  • 7
    • 67649207267 scopus 로고    scopus 로고
    • Engineering human IgG1 affinity to human neonatal Fc receptor: Impact of affinity improvement on pharmacokinetics in primates
    • 19494290 10.4049/jimmunol.0804182 1:CAS:528:DC%2BD1MXmslCnsb0%3D
    • YA Yeung MK Leabman JS Marvin J Qiu CW Adams S Lien, et al. 2009 Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates J Immunol 182 12 7663 71 19494290 10.4049/jimmunol.0804182 1:CAS:528:DC%2BD1MXmslCnsb0%3D
    • (2009) J Immunol , vol.182 , Issue.12 , pp. 7663-7671
    • Yeung, Y.A.1    Leabman, M.K.2    Marvin, J.S.3    Qiu, J.4    Adams, C.W.5    Lien, S.6
  • 8
    • 77950265888 scopus 로고    scopus 로고
    • Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-{alpha} antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys
    • 20071453 10.1124/dmd.109.031310 1:CAS:528:DC%2BC3cXhtVOgsrnN
    • R Deng KM Loyet S Lien S Iyer LE DeForge FP Theil, et al. 2010 Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-{alpha} antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys Drug Metab Dispos Biol Fate Chem 38 4 600 5 20071453 10.1124/dmd.109.031310 1:CAS:528:DC%2BC3cXhtVOgsrnN
    • (2010) Drug Metab Dispos Biol Fate Chem , vol.38 , Issue.4 , pp. 600-605
    • Deng, R.1    Loyet, K.M.2    Lien, S.3    Iyer, S.4    Deforge, L.E.5    Theil, F.P.6
  • 9
    • 0037314439 scopus 로고    scopus 로고
    • Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors
    • 10.1089/153685903321538026 1:CAS:528:DC%2BD3sXisleqtLY%3D
    • LA Khawli B Biela P Hu AL Epstein 2003 Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors Hybridoma Hybridomics 22 1 1 9 10.1089/153685903321538026 1:CAS:528: DC%2BD3sXisleqtLY%3D
    • (2003) Hybridoma Hybridomics , vol.22 , Issue.1 , pp. 1-9
    • Khawli, L.A.1    Biela, B.2    Hu, P.3    Epstein, A.L.4
  • 10
    • 33846404133 scopus 로고    scopus 로고
    • Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent
    • 17210705 10.1158/0008-5472.CAN-06-2531 1:CAS:528:DC%2BD2sXisFSmsQ%3D%3D
    • MS Dennis H Jin D Dugger R Yang L McFarland A Ogasawara, et al. 2007 Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent Cancer Res 67 1 254 61 17210705 10.1158/0008-5472.CAN-06-2531 1:CAS:528: DC%2BD2sXisFSmsQ%3D%3D
    • (2007) Cancer Res , vol.67 , Issue.1 , pp. 254-261
    • Dennis, M.S.1    Jin, H.2    Dugger, D.3    Yang, R.4    McFarland, L.5    Ogasawara, A.6
  • 11
    • 78650394814 scopus 로고    scopus 로고
    • Effects of charge on antibody tissue distribution and pharmacokinetics
    • 21053952 10.1021/bc100261d 1:CAS:528:DC%2BC3cXhtlynsb3N
    • CA Boswell DB Tesar K Mukhyala FP Theil PJ Fielder LA Khawli 2010 Effects of charge on antibody tissue distribution and pharmacokinetics Bioconjug Chem 21 12 2153 63 21053952 10.1021/bc100261d 1:CAS:528:DC%2BC3cXhtlynsb3N
    • (2010) Bioconjug Chem , vol.21 , Issue.12 , pp. 2153-2163
    • Boswell, C.A.1    Tesar, D.B.2    Mukhyala, K.3    Theil, F.P.4    Fielder, P.J.5    Khawli, L.A.6
  • 12
    • 78649663956 scopus 로고    scopus 로고
    • Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
    • 20818176 10.4161/mabs.2.6.13333
    • LA Khawli S Goswami R Hutchinson ZW Kwong J Yang X Wang, et al. 2010 Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats mAbs 2 6 613 24 20818176 10.4161/mabs.2.6.13333
    • (2010) MAbs , vol.2 , Issue.6 , pp. 613-624
    • Khawli, L.A.1    Goswami, S.2    Hutchinson, R.3    Kwong, Z.W.4    Yang, J.5    Wang, X.6
  • 13
    • 0024438061 scopus 로고
    • Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region
    • 2507634 1:CAS:528:DyaL1MXmtFejtrs%3D
    • MH Tao SL Morrison 1989 Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region J Immunol 143 8 2595 601 2507634 1:CAS:528:DyaL1MXmtFejtrs%3D
    • (1989) J Immunol , vol.143 , Issue.8 , pp. 2595-2601
    • Tao, M.H.1    Morrison, S.L.2
  • 14
    • 33644619972 scopus 로고    scopus 로고
    • Heterogeneity of recombinant antibodies: Linking structure to function
    • 1:CAS:528:DC%2BD28XntVOgsw%3D%3D
    • RJ Harris 2005 Heterogeneity of recombinant antibodies: linking structure to function Dev Biol 122 117 27 1:CAS:528:DC%2BD28XntVOgsw%3D%3D
    • (2005) Dev Biol , vol.122 , pp. 117-127
    • Harris, R.J.1
  • 15
    • 79958837668 scopus 로고    scopus 로고
    • High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
    • 21421994 10.1093/glycob/cwr027 1:CAS:528:DC%2BC3MXnsFWlur8%3D
    • AM Goetze YD Liu Z Zhang B Shah E Lee PV Bondarenko, et al. 2011 High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans Glycobiology 21 7 949 59 21421994 10.1093/glycob/ cwr027 1:CAS:528:DC%2BC3MXnsFWlur8%3D
    • (2011) Glycobiology , vol.21 , Issue.7 , pp. 949-959
    • Goetze, A.M.1    Liu, Y.D.2    Zhang, Z.3    Shah, B.4    Lee, E.5    Bondarenko, P.V.6
  • 16
    • 0025935612 scopus 로고
    • Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat
    • 1905196 1:STN:280:DyaK3M3nsFWjtA%3D%3D
    • JS Barrett JG Wagner SJ Fisher RL Wahl 1991 Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat Cancer Res 51 13 3434 44 1905196 1:STN:280:DyaK3M3nsFWjtA%3D%3D
    • (1991) Cancer Res , vol.51 , Issue.13 , pp. 3434-3444
    • Barrett, J.S.1    Wagner, J.G.2    Fisher, S.J.3    Wahl, R.L.4
  • 17
    • 77649211091 scopus 로고    scopus 로고
    • Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects
    • 19940229 10.1177/0091270009340782 1:CAS:528:DC%2BC3cXjvFyrtrk%3D
    • Z Xu Q Wang Y Zhuang B Frederick H Yan E Bouman-Thio, et al. 2010 Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects J Clin Pharmacol 50 3 276 84 19940229 10.1177/0091270009340782 1:CAS:528:DC%2BC3cXjvFyrtrk%3D
    • (2010) J Clin Pharmacol , vol.50 , Issue.3 , pp. 276-284
    • Xu, Z.1    Wang, Q.2    Zhuang, Y.3    Frederick, B.4    Yan, H.5    Bouman-Thio, E.6
  • 18
    • 24144455629 scopus 로고    scopus 로고
    • Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins
    • 16187939 10.1517/14712598.5.1.S37 1:CAS:528:DC%2BD2MXhtVGgtrrI
    • D Ternant G Paintaud 2005 Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins Expert Opin Biol Ther 5 Suppl 1 S37 47 16187939 10.1517/14712598.5.1.S37 1:CAS:528:DC%2BD2MXhtVGgtrrI
    • (2005) Expert Opin Biol Ther , vol.5 , Issue.SUPPL. 1 , pp. 37-47
    • Ternant, D.1    Paintaud, G.2
  • 19
    • 55449104956 scopus 로고    scopus 로고
    • Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations
    • 12866937 10.1208/ps050210
    • JD Andya CC Hsu SJ Shire 2003 Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations AAPS pharmSci 5 2 E10 12866937 10.1208/ps050210
    • (2003) AAPS PharmSci , vol.5 , Issue.2 , pp. 10
    • Andya, J.D.1    Hsu, C.C.2    Shire, S.J.3
  • 20
    • 0033302303 scopus 로고    scopus 로고
    • Transport of molecules, particles, and cells in solid tumors
    • 11701489 10.1146/annurev.bioeng.1.1.241 1:CAS:528:DyaK1MXnvFyit7c%3D
    • RK Jain 1999 Transport of molecules, particles, and cells in solid tumors Annu Rev Biomed Eng 1 241 63 11701489 10.1146/annurev.bioeng.1.1.241 1:CAS:528:DyaK1MXnvFyit7c%3D
    • (1999) Annu Rev Biomed Eng , vol.1 , pp. 241-263
    • Jain, R.K.1
  • 21
    • 33746491709 scopus 로고    scopus 로고
    • Drug penetration in solid tumours
    • 16862189 10.1038/nrc1893 1:CAS:528:DC%2BD28XntFGlu7w%3D
    • AI Minchinton IF Tannock 2006 Drug penetration in solid tumours Nat Rev Cancer 6 8 583 92 16862189 10.1038/nrc1893 1:CAS:528:DC%2BD28XntFGlu7w%3D
    • (2006) Nat Rev Cancer , vol.6 , Issue.8 , pp. 583-592
    • Minchinton, A.I.1    Tannock, I.F.2
  • 22
    • 77449119116 scopus 로고    scopus 로고
    • Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease
    • 19924542 10.1208/s12248-009-9157-5 1:CAS:528:DC%2BC3cXisVGrtrs%3D
    • M Tabrizi GG Bornstein H Suria 2010 Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease AAPS J 12 1 33 43 19924542 10.1208/s12248-009-9157-5 1:CAS:528:DC%2BC3cXisVGrtrs%3D
    • (2010) AAPS J , vol.12 , Issue.1 , pp. 33-43
    • Tabrizi, M.1    Bornstein, G.G.2    Suria, H.3
  • 23
    • 38749139878 scopus 로고    scopus 로고
    • Factors determining antibody distribution in tumors
    • 18179828 1:CAS:528:DC%2BD1cXhslOjsLw%3D
    • GM Thurber MM Schmidt KD Wittrup 2008 Factors determining antibody distribution in tumors Trends Pharmacol Sci 29 2 57 61 18179828 1:CAS:528:DC%2BD1cXhslOjsLw%3D
    • (2008) Trends Pharmacol Sci , vol.29 , Issue.2 , pp. 57-61
    • Thurber, G.M.1    Schmidt, M.M.2    Wittrup, K.D.3
  • 24
    • 0037908924 scopus 로고    scopus 로고
    • Monoclonal antibody radiopharmaceuticals: Cationization, pegylation, radiometal chelation, pharmacokinetics, and tumor imaging
    • 12757378 10.1021/bc0256648 1:CAS:528:DC%2BD3sXit1Ojt78%3D
    • HJ Lee WM Pardridge 2003 Monoclonal antibody radiopharmaceuticals: cationization, pegylation, radiometal chelation, pharmacokinetics, and tumor imaging Bioconjug Chem 14 3 546 53 12757378 10.1021/bc0256648 1:CAS:528:DC%2BD3sXit1Ojt78%3D
    • (2003) Bioconjug Chem , vol.14 , Issue.3 , pp. 546-553
    • Lee, H.J.1    Pardridge, W.M.2
  • 25
    • 57149110011 scopus 로고    scopus 로고
    • CNS delivery via adsorptive transcytosis
    • 18726697 10.1208/s12248-008-9055-2
    • F Herve N Ghinea JM Scherrmann 2008 CNS delivery via adsorptive transcytosis AAPS J 10 3 455 72 18726697 10.1208/s12248-008-9055-2
    • (2008) AAPS J , vol.10 , Issue.3 , pp. 455-472
    • Herve, F.1    Ghinea, N.2    Scherrmann, J.M.3
  • 26
    • 0033555629 scopus 로고    scopus 로고
    • The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points
    • 9927057 1:CAS:528:DyaK1MXntFOjtA%3D%3D
    • H Kobayashi N Le IS Kim MK Kim JE Pie D Drumm, et al. 1999 The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points Cancer Res 59 2 422 30 9927057 1:CAS:528:DyaK1MXntFOjtA%3D%3D
    • (1999) Cancer Res , vol.59 , Issue.2 , pp. 422-430
    • Kobayashi, H.1    Le, N.2    Kim, I.S.3    Kim, M.K.4    Pie, J.E.5    Drumm, D.6
  • 27
    • 0029776847 scopus 로고    scopus 로고
    • Improved tumor localization and radioimaging with chemically modified monoclonal antibodies
    • 10851539 10.1089/cbr.1996.11.203 1:CAS:528:DyaK28XkvFWgsrw%3D
    • LA Khawli MS Glasky MM Alauddin AL Epstein 1996 Improved tumor localization and radioimaging with chemically modified monoclonal antibodies Cancer Biother Radiopharm 11 3 203 15 10851539 10.1089/cbr.1996.11.203 1:CAS:528:DyaK28XkvFWgsrw%3D
    • (1996) Cancer Biother Radiopharm , vol.11 , Issue.3 , pp. 203-215
    • Khawli, L.A.1    Glasky, M.S.2    Alauddin, M.M.3    Epstein, A.L.4
  • 28
    • 84863230445 scopus 로고    scopus 로고
    • Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
    • 10.4161/mabs.4.2.19387
    • Y Zheng DB Tesar L Benincosa H Birnböck CA Boswell D Bumbaca, et al. 2012 Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration mAbs 4 2 0 1 10.4161/mabs.4.2.19387
    • (2012) MAbs , vol.4 , Issue.2 , pp. 0-1
    • Zheng, Y.1    Tesar, D.B.2    Benincosa, L.3    Birnböck, H.4    Boswell, C.A.5    Bumbaca, D.6
  • 29
    • 77951101786 scopus 로고    scopus 로고
    • Reduced elimination of IgG antibodies by engineering the variable region
    • 10.1093/protein/gzq009 1:CAS:528:DC%2BC3cXks1Gqtrw%3D
    • T Igawa H Tsunoda T Tachibana A Maeda F Mimoto C Moriyama, et al. 2010 Reduced elimination of IgG antibodies by engineering the variable region Protein Eng Des Sel PEDS 23 5 385 92 10.1093/protein/gzq009 1:CAS:528: DC%2BC3cXks1Gqtrw%3D
    • (2010) Protein Eng des Sel PEDS , vol.23 , Issue.5 , pp. 385-392
    • Igawa, T.1    Tsunoda, H.2    Tachibana, T.3    Maeda, A.4    Mimoto, F.5    Moriyama, C.6
  • 30
    • 34548229364 scopus 로고    scopus 로고
    • FcRn: The neonatal Fc receptor comes of age
    • 17703228 10.1038/nri2155 1:CAS:528:DC%2BD2sXpsV2qtbw%3D
    • DC Roopenian S Akilesh 2007 FcRn: the neonatal Fc receptor comes of age Nat Rev Immunol 7 9 715 25 17703228 10.1038/nri2155 1:CAS:528: DC%2BD2sXpsV2qtbw%3D
    • (2007) Nat Rev Immunol , vol.7 , Issue.9 , pp. 715-725
    • Roopenian, D.C.1    Akilesh, S.2
  • 31
    • 78951478220 scopus 로고    scopus 로고
    • Translational pharmacokinetics and pharmacodynamics of an FcRn-variant anti-CD4 monoclonal antibody from preclinical model to phase i study
    • 21191378 10.1038/clpt.2010.311 1:CAS:528:DC%2BC3MXpsVyltA%3D%3D
    • Y Zheng H Scheerens JC Davis Jr R Deng SK Fischer C Woods, et al. 2011 Translational pharmacokinetics and pharmacodynamics of an FcRn-variant anti-CD4 monoclonal antibody from preclinical model to phase I study Clin Pharmacol Ther 89 2 283 90 21191378 10.1038/clpt.2010.311 1:CAS:528:DC%2BC3MXpsVyltA%3D%3D
    • (2011) Clin Pharmacol Ther , vol.89 , Issue.2 , pp. 283-290
    • Zheng, Y.1    Scheerens, H.2    Davis Jr., J.C.3    Deng, R.4    Fischer, S.K.5    Woods, C.6
  • 32
    • 33746888249 scopus 로고    scopus 로고
    • Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
    • 16888140 10.1126/science.1129594 1:CAS:528:DC%2BD28Xnsl2hsbY%3D
    • Y Kaneko F Nimmerjahn JV Ravetch 2006 Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Science 313 5787 670 3 16888140 10.1126/science.1129594 1:CAS:528:DC%2BD28Xnsl2hsbY%3D
    • (2006) Science , vol.313 , Issue.5787 , pp. 670-673
    • Kaneko, Y.1    Nimmerjahn, F.2    Ravetch, J.V.3
  • 33
    • 33845590523 scopus 로고    scopus 로고
    • Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: The high-mannose, hybrid, and complex types
    • 17012310 10.1093/glycob/cwl057 1:CAS:528:DC%2BD28XhtlChtbrK
    • Y Kanda T Yamada K Mori A Okazaki M Inoue K Kitajima-Miyama, et al. 2007 Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types Glycobiology 17 1 104 18 17012310 10.1093/glycob/ cwl057 1:CAS:528:DC%2BD28XhtlChtbrK
    • (2007) Glycobiology , vol.17 , Issue.1 , pp. 104-118
    • Kanda, Y.1    Yamada, T.2    Mori, K.3    Okazaki, A.4    Inoue, M.5    Kitajima-Miyama, K.6
  • 34
    • 84856120429 scopus 로고    scopus 로고
    • Monoclonal antibodies: What are the pharmacokinetic and pharmacodynamic considerations for drug development?
    • 22248267 10.1517/17425255.2012.643868 1:CAS:528:DC%2BC38XhtV2itb8%3D
    • R Deng F Jin S Prabhu S Iyer 2012 Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development? Expert Opin Drug Metab Toxicol 8 2 141 60 22248267 10.1517/17425255.2012.643868 1:CAS:528:DC%2BC38XhtV2itb8%3D
    • (2012) Expert Opin Drug Metab Toxicol , vol.8 , Issue.2 , pp. 141-160
    • Deng, R.1    Jin, F.2    Prabhu, S.3    Iyer, S.4
  • 35
    • 38349123331 scopus 로고    scopus 로고
    • Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice
    • 1:CAS:528:DC%2BD1cXhtV2iu7w%3D
    • TA Millward M Heitzmann K Bill U Langle P Schumacher K Forrer 2008 Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice Biol J Int Assoc Biol Stand 36 1 41 7 1:CAS:528:DC%2BD1cXhtV2iu7w%3D
    • (2008) Biol J Int Assoc Biol Stand , vol.36 , Issue.1 , pp. 41-47
    • Millward, T.A.1    Heitzmann, M.2    Bill, K.3    Langle, U.4    Schumacher, P.5    Forrer, K.6
  • 36
    • 0032055988 scopus 로고    scopus 로고
    • Effect of C2-associated carbohydrate structure on Ig effector function: Studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells
    • 9531299 1:CAS:528:DyaK1cXitFWlt7w%3D
    • A Wright SL Morrison 1998 Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells J Immunol 160 7 3393 402 9531299 1:CAS:528:DyaK1cXitFWlt7w%3D
    • (1998) J Immunol , vol.160 , Issue.7 , pp. 3393-3402
    • Wright, A.1    Morrison, S.L.2
  • 37
    • 0034495971 scopus 로고    scopus 로고
    • In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure
    • 11159927 10.1093/glycob/10.12.1347 1:CAS:528:DC%2BD3MXlvFyhsg%3D%3D
    • A Wright Y Sato T Okada K Chang T Endo S Morrison 2000 In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure Glycobiology 10 12 1347 55 11159927 10.1093/glycob/10.12. 1347 1:CAS:528:DC%2BD3MXlvFyhsg%3D%3D
    • (2000) Glycobiology , vol.10 , Issue.12 , pp. 1347-1355
    • Wright, A.1    Sato, Y.2    Okada, T.3    Chang, K.4    Endo, T.5    Morrison, S.6
  • 38
    • 33646454717 scopus 로고    scopus 로고
    • Results of a randomized open-label crossover study of the bioequivalence of subcutaneous versus intramuscular administration of alefacept
    • 16638415
    • MT Sweetser J Woodworth S Swan B Ticho 2006 Results of a randomized open-label crossover study of the bioequivalence of subcutaneous versus intramuscular administration of alefacept Dermatol Online J 12 3 1 16638415
    • (2006) Dermatol Online J , vol.12 , Issue.3 , pp. 1
    • Sweetser, M.T.1    Woodworth, J.2    Swan, S.3    Ticho, B.4
  • 39
    • 75149158924 scopus 로고    scopus 로고
    • Bioavailability of golimumab, an anti-tumor necrosis factor-α human monoclonal antibody, administered subcutaneously at three different injection sites in healthy subjects
    • ZH Xu QM Wang YL Zhuang B Frederick H Yan JC Marini, et al. 2009 Bioavailability of golimumab, an anti-tumor necrosis factor-α human monoclonal antibody, administered subcutaneously at three different injection sites in healthy subjects Clin Pharmacol Ther 85 S1 S24
    • (2009) Clin Pharmacol Ther , vol.85 , Issue.S1 , pp. 24
    • Xu, Z.H.1    Wang, Q.M.2    Zhuang, Y.L.3    Frederick, B.4    Yan, H.5    Marini, J.C.6
  • 40
    • 77955447706 scopus 로고    scopus 로고
    • Subcutaneous administration of biotherapeutics: Current experience in animal models
    • 20677097 1:CAS:528:DC%2BC3cXhtlaktL%2FP
    • TA McDonald ML Zepeda MJ Tomlinson WH Bee IA Ivens 2010 Subcutaneous administration of biotherapeutics: current experience in animal models Curr Opin Mol Ther 12 4 461 70 20677097 1:CAS:528:DC%2BC3cXhtlaktL%2FP
    • (2010) Curr Opin Mol Ther , vol.12 , Issue.4 , pp. 461-470
    • McDonald, T.A.1    Zepeda, M.L.2    Tomlinson, M.J.3    Bee, W.H.4    Ivens, I.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.